Last Thursday, Dr. Anthony Fauci of the National Institute of Allergy and Infectious Diseases, said the organization would work with the Food and Drug Administration to fast-track an Ebola vaccine. Trials in humans could begin as early as September. UTMB’s Tom Geisbert is working on a vaccine that was given to monkeys after they were exposed to Ebola. The vaccine “completely [protected] them all the time with a single shot,” he said. Vaccines are usually given before a person is at risk of infection, but some vaccines, like the rabies vaccine and this one, are given after exposure. A second potential treatment involves a small molecule that binds to Ebola’s genes and stops them from making more copies of the virus. It was found to be safe in humans, but since the test subjects didn’t have Ebola, more tests are needed.